Financial Report
1 January - 31 December
kEUR |
Note |
2021 |
2020 |
|
|
|
|
Result for the year |
|
47,258 |
31,335 |
|
|
|
|
Other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
|
|
Exchange differences on translation of foreign operations, net of tax |
|
14,901 |
-2,922 |
Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
14,901 |
-2,922 |
|
|
|
|
Other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
|
|
Remeasurement gain / (loss) on defined benefit plans |
|
1,187 |
-240 |
Income tax effect |
5 |
-354 |
71 |
Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
833 |
-169 |
Other comprehensive result for the year, net of taxes |
|
15,734 |
-3,091 |
|
|
|
|
Total comprehensive result for the year, net of taxes |
|
62,992 |
28,244 |
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
62,992 |
28,244 |